Search Results for "Bioequivalence Study Design Cephalexin"
Original Source: Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules
A single dose, two treatments (two cephalexin capsules brands), two sequences, cross-over design was used with a washout of 7 days between the two study periods. Treatment groups balanced with the same number of healthy volunteers who were randomly (in two strata: male and female) assigned to the study drug administration sequences.
Matching Channels
SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Rece...
Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyle...
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in term...
Gynecology is the study of diseases affecting the reproductive organs of women and girls. Add the Gynecology News Channel to your RSS reader;
Matching News
FDA Approving More ANDAs That Use Novel Bioequivalence Methods
OGD officials report on the progress being made in approving generic drugs using more novel and science-based bioequivalence methods than in the past. Officials impart tips on how to submit review-rea...
Azaya Therapeutics commences ATI-0918 bioequivalence study in ovarian cancer
Azaya Therapeutics, Inc. today announced the initiation of a bioequivalence study of ATI-0918 in patients with ovarian cancer.
Type: Original PaperThe purpose of this investigation is to evaluate the scientific benefits of a novel approach in using stable isotopes to reduce the number of subjects needed to perform relative bi...
New data shows value of morphologically directed Raman spectroscopy for bioequivalence studies
A new application note on the Malvern Instruments website describes the use of morphologically directed Raman microscopy in assessing the bioequivalence of a generic and innovator drug with a dual act...
RedHill bioequivalence trial with RHB-103 meets specified endpoints
RedHill Biopharma has announced positive results from a pivotal bioequivalence trial with RHB-103, an oral thin-film formulation of Rizatriptan for the treatment of acute migraine.
Generic Bupropion XL Reevaluation Running Behind Schedule
FDA has received data from just one of four bioequivalence studies of 300 mg bupropion extended-release generics it requested by March from sponsors following Impax/Teva’s withdrawal of their generi...
Type: ReportThis summary workshop report highlights presentations and over-arching themes from an October 2011 workshop. Discussions focused on best practices in the application of biopharmaceutics in...
Type: Brief Communication“For-cause” inspections are initiated during the review of bioequivalence (BE) data submitted to Abbreviated New Drug Applications when possible scientific misconduct and...
Matching PubMed Articles
Selection of CMY-2 producing Escherichia coli in the faecal flora of dogs treated with cephalexin.
Cephalexin is a first generation cephalosporin commonly used in dogs for treatment of pyoderma. The objective of this study was to evaluate the in vivo effects of cephalexin on selection of Escherichi...
The Effect of Staggered Administration of Zinc Sulfate on the Pharmacokinetics of Oral Cephalexin*
"What this paper adds statement": a) What is already known about the subject: • Zinc supplementation is an important intervention against mortality from infectious disease. • Many patients using z...
In the European Union multiple dose bioequivalence studies are required for the approval of generic prolonged-release products, but they are not required by the US-FDA. In order to investigate if the...
Pharmacodynamic bioequivalence testing.
What is known and Objective: The assessment of bioequivalence of drugs intended for local action/targeted delivery and with poor systemic absorption presents unique challenges. Approaches such as p...
The pharmacokinetic profile and bioavailability of a long-acting formulation of cephalexin after intramuscular administration to cats was investigated. Single intravenous (cephalexin lysine salt) and...
